This product is primarily metabolized by CYP3A4 and flavin-containing monooxygenase (FMO1 and FMO3), and urinary excretion of unchanged drug was 14.8% to 22.1% (see Pharmacology: Pharmacokinetics under Actions). (See Table 12.)
Click on icon to see table/diagram/image